EIF.DU EIFELHOEHEN-KLINIK

Other Metals & Mining Dusseldorf Exchange
- EUR
Market cap
-
P/E
3.7x
P/B
0.75x
ROE
17.8%
Dividend yield
-
Fundamental score
2.9/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is EIF.DU undervalued?

Graham number

The Graham number of EIFELHOEHEN-KLINIK cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

EIFELHOEHEN-KLINIK fundamental analysis

15 of 22 checks passed

ROE 1/2

Moderate return on equity (17.8%), between 10% and 20%.

ROA 1/1

Return on assets (6.7%) is above the industry median (3.8%).

Profit Consistency 1/2

Profitable for 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (2,877.8%) is above the industry median (7.9%).

Revenue Growth 2/2

Revenue grew 12.0% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 1/2

Moderate debt to equity (76.9%), up to 100%.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 6.5x against interest expense, well covered.

PE vs Market 1/1

PE (3.7x) is below the market median (18.2x).

PE vs Industry 1/1

PE (3.7x) is below the industry median (18.3x).

PBV 1/1

Price to book (0.8x) is below the industry median (2.0x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 2.8, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

EIFELHOEHEN-KLINIK stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About EIFELHOEHEN-KLINIK

There is no Profile data available for EIF.DU.

Full company profile